Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT04506528
Official study title

COVID EHR COHORT at the University of Wisconsin

Study summary

This cohort study will obtain electronic health record (EHR) data (limited data set) from 21 health systems affiliated with the Cancer Center Cessation Initiative (C3I) network or health systems with large numbers of COVID-19 patients to explore whether smoking status, cancer history, and other risk factors among patients diagnosed with COVID-19 are associated with mortality and/or COVID-19 disease severity/complications. Each site will provide data from their health system EHR on a regular basis that includes all patients identified as having COVID-19 at some point in the interval from February 1, 2020, through January 31, 2022.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forCOVID-19 · Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 31, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Wisconsin, Madison

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Wisconsin, Madison
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • COVID-19 ICD-10-CM diagnosis (U07.1 or J12.82) during a healthcare visit and/or
  • COVID-19 positive PCR test and/or
  • COVID-19 positive antigen test
Reasons someone may not be able to joinExclusion criteria

N/A

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and InterventionMadison, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 31, 2022. Always confirm current availability with the study team.

View original record ↗